Latest Breaking News On - Scott halsted - Page 2 : comparemela.com

SPR Therapeutics closes $37 million in Series D funding

Revelation Partners Expands Team with New Appointments Dr. Doug Fisher, Partner and Liz Staley, Chief Compliance Officer

Revelation Partners is Lead Investor Backing Rosetta Capital to Purchase Seven Biotech Assets From Schroder UK Public Private Trust plc

Revelation Partners Closes Third Healthcare Fund at $350M

Revelation Partners Closes Revelation Healthcare Fund III at Hard Cap of $350MM

Revelation Partners Closes Revelation Healthcare Fund III at Hard Cap of $350MM News provided by Share this article Share this article SAN FRANCISCO, March 16, 2021 /PRNewswire/  Revelation Partners, a dedicated secondary investor in healthcare, announced the first and final closing of its newest fund, Revelation Healthcare Fund III, at its hard cap of $350 million. The oversubscribed offering surpassed the initial target of $300 million and builds on the long-term investment success of the firm. The firm, which now manages over $900 million of committed capital, specializes in providing shareholder liquidity, GP solutions, and growth capital for private healthcare companies and investors. The firm invests broadly across all healthcare sub-sectors, including medical devices, diagnostics, biotech, healthcare technology and healthcare services.